Laryngeal Mask Market (2024 - 2030)

Report Overview

The global laryngeal mask market size was valued at USD 672.5 million in 2023 and is projected to grow from USD 814.6 million in 2026 to USD 1,011.1 million by 2030, at a CAGR of 6.0% from 2024 to 2030. North America dominated the market, accounting for a revenue share of 42.5% in 2023. The growth can be attributed to the increasing product usage during surgeries or during anesthesia procedures. The upsurge in the number of surgical procedures coupled with the increasing demand for disposable devices is the key driver of the market for laryngeal masks.

Source: Grand View Research, IR Documents, Primary Interviews, Paid Databases

To learn more about this report, Download Free Sample Report

In addition, the burgeoning prevalence of chronic diseases that require surgeries and anesthesia is fueling the product demand, thereby boosting the market growth. For instance, according to medico-legal data provided by the Healthcare Insurance Reciprocal of Canada (HIROC) & Canadian Medical Protective Association (CMPA), more than 1 million surgical procedures are performed yearly in the country; which, drives the demand for laryngeal masks.

To learn more about this report, Download Free Sample Report

The COVID-19 pandemic is caused by a coronavirus that is transmitted primarily via droplets, aerosol, or direct contact. This has caused higher infection risk to anesthetists due to their recurrent involvement in aerosol-generating airway interventions. This has caused the slow adoption of laryngeal masks during the pandemic. Various anesthetic guidelines have emerged due to coronavirus outbreak; underlying management principles include protecting healthcare workers and minimizing aerosol contamination.

The rising number of technological developments is also anticipated to boost the growth of the market for the laryngeal mask. Moreover, increasing investments in R&D and demand for laryngeal mask airway ventilation is expected to fuel the demand over the forecast period. There is high competition between key players, which has prioritized R&D and innovation in the existing product portfolio.

Furthermore, according to a report by Congressional Research Service, in 2018, the federal funding for R&D in the U.S. increased from USD 2.8 billion in 1953 to USD 127.2 billion in 2018. These factors drive R&D activities in the U.S. and are expected to support the market for laryngeal masks. The rising geriatric population is further propelling the market for the laryngeal mask. Elderly people are susceptible to chronic diseases that often lead to surgeries.

Therefore, the growing geriatric population is anticipated to increase the number of cases of several long-term diseases. According to the Population Reference Bureau report named “Aging in the United States”, there will be an estimated increase from 48 million in 2016 to 98 million by 2060 in the geriatric population in the country. Such factors are likely to increase product demand in the coming years.

Type Insights

The disposable type segment dominated the market for laryngeal masks and accounted for the largest revenue share of over 57.5% in 2020 owing to associated benefits with its usage. It offers a comfortable airway in patients while eliminating the possibility of disease transmission as they are not reused. Moreover, laryngeal masks have a comparatively stable intracuff pressure during nitrous oxide anesthesia. Such factors are augmenting segment growth. The reusable type segment is anticipated to witness a lucrative CAGR of 5.3% over the forecast period. The reduced cost per patient with the use of these masks is attributing to its rising adoption. Furthermore, ample availability of reusable laryngeal masks and comparatively more compliant in vitro use boost their demand.

Patient Insights

The adult patients segment dominated the laryngeal mask market and accounted for the largest revenue share of more than 58.8% in 2020. This can be attributed to the comparatively larger demographic in this segment. The segment will expand further at a steady CAGR on account of the increasing number of surgeries performed and the high prevalence of chronic diseases in adults.

According to the International Journal of Environmental Research and Public Health, approximately half of U.S. citizens suffer from a minimum of one chronic disorder. This shows the potential burden of chronic conditions that are expected to drive the market for laryngeal masks in the near future.

End-use Insights

Based on the end-user, the hospitals and clinics segment held the maximum revenue share of over 60.3% in the market for laryngeal masks in 2020. The segment will retain the dominant position throughout the forecast years due to easy access and availability of favorable reimbursement policies, such as Medicare, and Blue Cross Blue Shield.

To learn more about this report, Download Free Sample Report

The Ambulatory Surgical Centers (ASCs) segment is projected to register the fastest CAGR of 6.4% over the forecast period. Factors, such as shorter stay duration, reduced wait-times, and personalized care, have increased the demand for outpatient services, thus increasing the number of surgeries conducted in ASCs.

Regional Insights

North America held the largest revenue share of over 43.6% in 2020 in the market for laryngeal masks, due to the presence of well-established healthcare infrastructure in the region. The growth can also be attributed to the standard regulatory mandates and implementation of practice guidelines released by the healthcare organizations in this region. Moreover, the increasing adoption of anesthesia during surgeries is driving product demand.

On the other hand, Asia Pacific is likely to register the fastest CAGR over the forecast years. The growth is attributed to the factors, such as the presence of a greater patient pool demanding high-quality healthcare solutions at lower costs, rising geriatric population, and increased focus of market players on the emerging countries of the region.

Key Companies & Market Share Insights

Most of the companies have undertaken several business strategies, such as new product launches, strategic collaborations, and regional expansion, as emerging countries are still in the loop of adopting the product, to gain a competitive edge. For instance, in May 2016, Medtronic PLC started a new regional headquarter in Singapore to strengthen its operations and meet the rising demand for healthcare in the Asia Pacific. These types of initiatives are projected to further encourage strategic developments in the market, thereby fueling its growth. Some of the prominent players in the laryngeal mask market include:

• Teleflex Inc.

• Intersurgical Ltd.

• Dynarex Corp.

• Medtronic PLC

• Ambu A/S

• Hitec Medical Co., Ltd.

• McKesson Corp.

• Thermo Fisher Scientific Inc.

• Anandic Medical Systems

• Narang Medical

• Besmed Health Business Corp.

• Vogt Medical Vertrieb GmbH

• Ferno

• Hsiner

• Legend Medical Devices, Inc.

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2028. For the purpose of this report, Grand View Research has segmented the global laryngeal mask market report on the basis of type, patient, end-use, and region:

• Type Outlook (Revenue, USD Million, 2016 - 2028)

  • Reusable laryngeal masks

  • Disposable laryngeal masks

• Patient Outlook (Revenue, USD Million, 2016 - 2028)

  • Children

  • Adult

  • Geriatric

• End-use Outlook (Revenue, USD Million, 2016 - 2028)

  • Hospitals & Clinics

  • Ambulatory Surgical Centers

• Regional Outlook (Revenue, USD Million, 2016 - 2028)

  • North America

    • U.S.

    • Canada

  • Europe

    • Germany

    • U.K.

    • France

    • Italy

    • Spain

  • Asia Pacific

    • Japan

    • China

    • India

    • South Korea

    • Australia

  • Latin America

    • Brazil

    • Mexico

    • Argentina

  • Middle East and Africa (MEA)

    • Saudi Arabia

    • UAE